Harvey-Bradshaw Index (HBI) for Crohn's Disease

General well-being (for previous day)

Abdominal pain (for the previous day)

Abdominal mass

Arthralgia

Uveitis

Erythema nodosum

Aphthous ulcers

Pyoderma gangrenosum

Anal fissures

New fistula

Abscess

Number of liquid/soft stools (previous day)

References

Frank I Scott. AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.. Gastroenterology, 2025
Torsten Kucharzik. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1.. Journal of Crohn's & colitis, 2025
Xavier Calvet. Patient-Reported Outcome Measures Poorly Correlate with Objective Inflammatory Bowel Disease Activity Measures: A Systematic Review.. Journal of Crohn's & colitis, 2025
Fabio Salvatore Macaluso. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.. Autoimmunity reviews, 2024
Jana G Hashash. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.. Gastroenterology, 2024
Ashwin N Ananthakrishnan. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease.. Gastroenterology, 2023
Eelco C Brand. Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020
Andreas Sturm. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.. Journal of Crohn's & colitis, 2019